CDR+NACC FTLD global rating at baseline | Mutation carriers | Controls | ||||
0 | 0.5 | 1 | 2 | 3 | ||
N | 140 | 30 | 22 | 23 | 16 | 145 |
FRS % Score | ||||||
Annualised change | −0.5 (8.2) | −2.3 (9.9) | −10.2 (18.6)*, † | −9.6 (16.6)*, † | −2.7 (8.3) | −0.1 (6.0) |
CDR+NACC-FTLD-SB | ||||||
Annualised change | 0.2 (0.9)* | 0.6 (2.7) | 3.0 (4.1)*, †, ‡ | 4.4 (4.0)*, †, ‡, § | 1.7 (3.3)* | −0.1 (0.4) |
Values are mean (SD) unless stated.
CDR+NACC FTLD=CDR Dementia Staging Instrument plus Behaviour and Language domains from the NACC FTLD module.
*P<0.05 versus controls
†P<0.05 versus baseline CDR+NACC FTLD global rating=0
‡P<0.05 versus baseline CDR+NACC FTLD global rating=0.5
§P<0.05 versus baseline CDR+NACC FTLD global rating=3.
CDR, Clinical Dementia Rating; FRS, Frontotemporal dementia Rating Scale; FTLD, Frontotemporal Lobar Degeneration; NACC, National Alzheimer’s Disease Coordinating Center.